BIO.News Newsletter

We have details on a new study about who really funds FDA-approved medicines, and a bill making its way through the Senate that would boost R&D and the bioeconomy. We’re also watching a House Ways & Means Committee hearing with USTR; we’ll have more on that tomorrow. (716 words, 3 minutes, 34 seconds)

Ahead of congressional hearings today and tomorrow on the Biden administration’s trade policy agenda, we’re unpacking two critical global trade issues: IP protections for COVID-19 vaccines and Mexico’s response to gene-edited agricultural products, specifically corn. (892 words, 4 minutes, 27 seconds)

Today’s all about the kids. The FDA authorized the use of Pfizer’s vaccine in younger teens, and Amyris announced a new partnership to help families and babies in need stay safe during the pandemic. Here’s what you need to know—plus how you can help. (698 words, 3 minutes, 29 seconds)

Starting a new week with a discussion on why diversity has been lacking in clinical trials—and what the industry can do about it. Listen to the latest episode of the I AM BIO Podcast or keep reading. We also have sweet news for plastic pollution and news on a historic nominee at USDA. (712 words, 3 minutes, 33 seconds)

Ending the week with a lot of promising news out of Europe. Germany’s not in favor of a waiver on vaccine patents—and the EU is still deciding. Meanwhile, it looks like the tide could be turning when it comes to gene editing in Europe. (662 words, 3 minutes, 18 seconds)

The Biden administration announced yesterday that they support the proposed “TRIPS” waiver of IP protections for COVID-19 vaccines. We explain why this harms American workers and innovation—and won’t help get vaccines to people around the world who need them the most. (554 words, 2 minutes, 46 seconds)

From drug price controls in the House, to the TRIPS waiver at the WTO in Geneva, it’s a busy day for drug-related debates. It’s also Cinco de Mayo, so we look at how gene editing is saving the classic Tex-Mex taco. (954 words, 4 minutes, 46 seconds)

It’s a big news day. BIO is proposing a program to help get COVID-19 vaccines and therapeutics to patients who need them most—wherever they are in the world—as well as a plan for helping farmers take advantage of carbon credits. (794 words, 3 minutes, 58 seconds)

Starting a new week and month with a roundup of all the vaccine developments you might have missed, plus a few cool examples of how biotech and biomanufacturing can help tackle climate change. (890 words, 4 minutes, 27 seconds)

Ending the week with nearly 100 million Americans fully vaccinated (H/T Axios Vitals)—and a look at how we can address climate change and future pandemics. Enjoy the weekend. (671 words, 3 minutes, 21 seconds)